Direct rosiglitazone action on steroidogenesis and proinflammatory factor production in human granulosa-lutein cells.

Reprod Biol Endocrinol · 2009 · PMC2797791 · PMID 20003221

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Likewise, co-treatment with hCG demonstrated a decreasing trend on E 2 and progesterone production, but did not achieve a significant difference.

also in 47,180 other papers

did not reach statistical significanceno p-value reported

Rosiglitazone decreased IL-6 secretion, whereas did not reach statistical significance.

also in 111,027 other papers

did not achieve significanceno p-value reported

Whereas IL-6 secretion after rosiglitazone treatment appeared to decrease, although this did not achieve significance.

also in 1,397 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.